Concepedia

Haixiang Xie

HX

Statistics

Publications

6

Citations

148

H-Index

6

Active since

2020

Affiliations

First Affiliated Hospital of GuangXi Medical University(Current)

Guangxi Medical University

Guangxi University

Haixiang Xie is an author at First Affiliated Hospital of GuangXi Medical University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2020–2024

6

Publications

6

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling

Xin Zhou, Jianzhu Luo, Haixiang Xie et al. · Cell Death Discovery · 2022 · 51 citations · Full text

, , +17

A three-stage robust dispatch model considering the multi-uncertainties of electric vehicles and a multi-energy microgrid

Haixiang Xie, Shan Gao, Junyi Zheng et al. · International Journal of Electrical Power & Energy Systems · 2024 · 33 citations · Full text

, , +16

circHIPK3 Acts as Competing Endogenous RNA and Promotes Non‐Small‐Cell Lung Cancer Progression through the miR‐107/BDNF Signaling Pathway

Weijun Hong, Yajuan Zhang, Jingyi Ding et al. · BioMed Research International · 2020 · 26 citations · Full text

, , +17

Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response

Yongguang Wei, Chenlu Lan, Chengkun Yang et al. · Scientific Reports · 2023 · 15 citations · Full text

, , +17

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration

Jusen Nong, Xin Zhou, Jun‐qi Liu et al. · Cancer Medicine · 2023 · 12 citations · Full text

, , +17

1–5 of 6